Krajina: Spojené kráľovstvo
Jazyk: angličtina
Zdroj: MHRA (Medicines & Healthcare Products Regulatory Agency)
Cimetidine
Chemidex Pharma Ltd
A02BA01
Cimetidine
800mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 01030100; GTIN: 5050204100216
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. Package leaflet: Information for the user Tagamet 800 mg tablets cimetidine What is in this leaflet 1. What Tagamet tablets are and what they are used for 2. What you need to know before you take Tagamet tablets 3. How to take Tagamet tablets 4. Possible side effects 5. How to store Tagamet tablets 6. Contents of the pack and other information 1. What Tagamet tablets are and what they are used for Tagamet tablets contain cimetidine which is a histamine H 2 antagonist. It helps to reduce the natural production of acid in the stomach. They are used to treat and relieve: the symptoms of peptic ulcers which occur in the stomach or intestine (gut) oesophageal reflux disease which can be caused when food and acid from the stomach washes back into the food pipe (oesophagus). This can cause a burning feeling in the chest known as heartburn a rare condition called Zollinger-Ellison syndrome when the stomach produces very large amounts of acid. This medicine may also be prescribed for a range of other medical conditions where a reduction of acid production in the stomach is needed, or to protect your stomach from other medicines (such as non-steroidal anti-inflammatories). 2. What you need to know before you take Tagamet tablets Do not take Tagamet tablets: • if you are allergic to cimetidine or to any of the other ingredients of this medicine (listed in section 6). If this applies to you, speak to your doctor or pharmacist. Warnings and precautions Talk to your doctor b Prečítajte si celý dokument
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Tagamet 800mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains Cimetidine 800 mg. Excipients with known effect: contains sodium 1.5 mg. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet. Pale green, oval, film-coated tablet engraved with Tagamet on one face and 800 on the reverse. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Tagamet is a histamine H 2 -receptor antagonist which rapidly inhibits both basal and stimulated gastric secretion of acid and reduces pepsin output. Tagamet is indicated in the treatment of duodenal and benign gastric ulceration including that associated with non-steroidal anti-inflammatory agents, recurrent and stomal ulceration, oesophageal reflux disease and other conditions where reduction of gastric acid by Tagamet has been shown to be beneficial: persistent dyspeptic symptoms with or without ulceration, particularly meal-related upper abdominal pain, including such symptoms associated with non-steroidal anti-inflammatory agents; the prophylaxis of gastrointestinal haemorrhage from stress ulceration in critically ill patients; before general anaesthesia in patients thought to be at risk of acid aspiration (Mendelson’s) syndrome, particularly obstetric patients during labour; to reduce malabsorption and fluid loss in the short bowel syndrome; and in pancreatic insufficiency to reduce degradation of enzyme supplements. Tagamet is also recommended in the management of Zollinger-Ellision syndrome. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The total daily dose should not normally exceed 2.4g. Dosage should be reduced in patients with impaired renal function (see section 4.4). Posology _Adults:_ For patients with duodenal or benign gastric ulceration a single dose of 800 mg at bedtime is recommended. Otherwise the usual dose is 400 mg twice a day with breakfast and at bedtime. Other effective regimens are 200 mg three times a day with meals and 400 mg at b Prečítajte si celý dokument